Plasma Therapy Market Size and Forecasts (2020-2030)

Plasma Therapy Market Size and Forecasts (2020 – 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: Type (Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin, and Leukocyte-Rich Fibrin), Source (Autologous and Allogeneic), Application (Orthopedic Conditions, Dermatology, Dental Issues, and Others),  End User (Hospitals and Clinics, Research Institutes, and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

Send Enquiry

$3,633$6,433

Description

The plasma therapy market is expected to grow from US$ 0.390 billion in 2022 to US$ 1.097 billion by 2030; the market is estimated to register a CAGR of 13.80% from 2022 to 2030. Key factors driving the market growth include the rising cases of orthopedic disorders in people, especially in the geriatric population, the rising number of joint and muscle injuries in athletes, and the surging demand for minimally invasive cosmetic procedures.
Platelet-rich plasma (PRP) is a form of regenerative medicine that amplifies natural growth factors in blood to heal tissue. It entails the utilization of the blood plasma obtained from individuals who have successfully recovered from an illness to address the range of medical conditions and foster the process of healing. PRP treatments find applications in orthopedics for the treatment of joint injuries, dermatology in skin rejuvenation procedures, and dentistry for tissue repair
Rising Cases of Orthopedic Disorders and muscle Injuries and Increasing Use of PRP in Aesthetic Procedures Drive Plasma Therapy Market Growth
According to statistics published by the World Health Organization (WHO) in 2023, ~528 million people across the world were living with osteoarthritis (OA) in 2019, representing an increase of 113% since 1990. An article published in PubMed Central in December 2020 states that the use of PRP offers potential for tissue repair due to the abundance of growth factors and cytokines in this plasma, which are crucial in initiating and modulating regenerative microenvironments for both soft and hard tissues. PRP therapy can be used in the healing of bone fractures, ligament, muscle, and tendon injuries, peripheral nerve injuries, articular cartilage lesions, and osteoarthritis. Therefore, there is a high demand for plasma therapies in orthopedic and tissue repair procedures.
Moreover, PRP is used in cosmetic surgeries for skin rejuvenation, anti-aging, and other aesthetic procedures. Out of 73 studies evaluated in a review published in PubMed Central in November 2021, 45 studies focused on PRP monotherapy, while 35 studies investigated the effects of PRP in combination with microneedling. As a result, the therapies were well-tolerated and suitable for all phototypes. Positive treatment outcomes were identified for various conditions, including skin rejuvenation, scar revision, alopecia, pigmentary disorders, lichen sclerosis, leprosy-induced peripheral neuropathy, plaque psoriasis, and nail disorders.
Therefore, the use of PRP in cosmetic surgeries contributes to the growth of the plasma therapy market.

Market Opportunity
Use of PRP in Combination Therapies
PRP therapy is an evolving treatment method with several applications in dermatology, particularly for hair restoration, skin rejuvenation, acne scars, dermal augmentation, and striae distensae. Using PRP together with laser therapies, microneedling, dermal fillers, and autologous fat grafting can result in better aesthetic outcomes due to synergistic effects. However, there is a need for standardization of PRP treatment protocols for specific conditions. PRP has great potential in dermatology, and its therapeutic applications are continuously expanding. Many studies have been conducted to assess the effect of PRP in combined medical therapy for various dermatological disorders such as androgenetic alopecia, vitiligo, and skin rejuvenation. For instance, a study, “Evaluation of adding platelet-rich plasma to combined medical therapy in androgenetic alopecia,” published by PubMed Central in 2021, was carried out on 126 patients suffering from Androgenetic alopecia (AGA), a common hair loss disorder, the study concluded that the integration of “PRP with micro-needling” to the combined medical therapy in AGA boosts its efficacy and reduces the time required for maximum improvement.
Similarly, in another article published by Wiley Online Library in November 2020, a study was carried out to assess various combination therapy strategies for treating vitiligo. The study included eleven studies with 670 cases. It concluded that in comparison to monotherapy, the clinical improvement of re-pigmentation was significantly higher when using a combination of 308-nm excimer laser and PRP. Similarly, a combination of fractional carbon dioxide laser and PRP resulted in a higher mean improvement grade of re-pigmentation.
Therefore, the introduction of PRP-combination therapies is creating various opportunities in the plasma therapy market.
SEGMENTAL OVERVIEW
The plasma therapy market is segmented on the basis of type, source, application, end product, and end user. In terms of type, the market is segmented into pure PRP, leukocyte-rich PRP, pure platelet-rich fibrin, and leukocyte-rich fibrin. The pure platelet-rich fibrin segment held the largest market share in 2022 and is anticipated to register the highest CAGR during 2022–2030. Leukocyte-rich PRP (LR-PRP) is a type of PRP that has a higher concentration of neutrophils (white blood cells) than the baseline level. It is generally associated with proinflammatory effects. However, in some cases, LR-PRP can be beneficial to stimulate inflammation in the body to indicate a chronic condition such as tendinopathy.
The plasma therapy market, by source, is bifurcated into autologous and allogeneic. The autologous segment dominated the market in 2022, and the allogeneic segment is anticipated to record a higher CAGR during 2022–2030. Autologous PRP injection is a secure and reliable biological technique that is used for the treatment of different musculoskeletal disorders. PRP injection can effectively support the primary treatment of patients with chronic autoimmune inflammatory diseases such as rheumatoid arthritis by suppressing the production of inflammatory cytokines and promoting the growth of synovial fibroblasts.

Summary Info

Industry:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

NA

NA

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Market Attractiveness Analysis
3. Research Methodology
4. Plasma Therapy Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Plasma Therapy Market – Key Market Dynamics
5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints
6. Plasma Therapy Market – Global Market Analysis
6.1 Plasma Therapy – Global Market Overview
6.2 Plasma Therapy – Global Market and Forecast to 2030
7. Plasma Therapy Market – Revenue Analysis (USD Million) – By Type, 2020-2030
7.1 Overview
7.2 Pure PRP
7.3 Leukocyte-Rich PRP
7.4 Pure Platelet-Rich Fibrin
7.5 Leukocyte-Rich Fibrin
8. Plasma Therapy Market – Revenue Analysis (USD Million) – By Source, 2020-2030
8.1 Overview
8.2 Autologous
8.3 Allogenic
9. Plasma Therapy Market – Revenue Analysis (USD Million) – By Application, 2020-2030
9.1 Overview
9.2 Orthopedic
9.3 Dermatology
9.4 Cardiac Muscle Injury
9.5 Dental
9.6 Nerve Injury
9.7 Others
10. Plasma Therapy Market – Revenue Analysis (USD Million) – By End Products Produce , 2020-2030
10.1 Overview
10.2 Albumin
10.3 Immunoglobulin G (IgG)
10.4 Others
11. Plasma Therapy Market – Revenue Analysis (USD Million) – By End User, 2020-2030
11.1 Overview
11.2 Hospitals and Clinics
11.3 Research Institutes
11.4 Ambulatory Surgical Centers
12. Plasma Therapy Market – Revenue Analysis (USD Million), 2020-2030 – Geographical Analysis
12.1 North America
12.1.1 North America Plasma Therapy Market Overview
12.1.2 North America Plasma Therapy Market Revenue and Forecasts to 2030
12.1.3 North America Plasma Therapy Market Revenue and Forecasts and Analysis – By Type
12.1.4 North America Plasma Therapy Market Revenue and Forecasts and Analysis – By Source
12.1.5 North America Plasma Therapy Market Revenue and Forecasts and Analysis – By Application
12.1.6 North America Plasma Therapy Market Revenue and Forecasts and Analysis – By End Products Produce
12.1.7 North America Plasma Therapy Market Revenue and Forecasts and Analysis – By End User
12.1.8 North America Plasma Therapy Market Revenue and Forecasts and Analysis – By Countries
12.1.8.1 United States Plasma Therapy Market
12.1.8.1.1 United States Plasma Therapy Market, by Type
12.1.8.1.2 United States Plasma Therapy Market, by Source
12.1.8.1.3 United States Plasma Therapy Market, by Application
12.1.8.1.4 United States Plasma Therapy Market, by End Products Produce
12.1.8.1.5 United States Plasma Therapy Market, by End User
12.1.8.2 Canada Plasma Therapy Market
12.1.8.2.1 Canada Plasma Therapy Market, by Type
12.1.8.2.2 Canada Plasma Therapy Market, by Source
12.1.8.2.3 Canada Plasma Therapy Market, by Application
12.1.8.2.4 Canada Plasma Therapy Market, by End Products Produce
12.1.8.2.5 Canada Plasma Therapy Market, by End User
12.1.8.3 Mexico Plasma Therapy Market
12.1.8.3.1 Mexico Plasma Therapy Market, by Type
12.1.8.3.2 Mexico Plasma Therapy Market, by Source
12.1.8.3.3 Mexico Plasma Therapy Market, by Application
12.1.8.3.4 Mexico Plasma Therapy Market, by End Products Produce
12.1.8.3.5 Mexico Plasma Therapy Market, by End User
Note – Similar analysis would be provided for below mentioned regions/countries

12.2 Europe
12.2.1 Germany
12.2.2 France
12.2.3 Italy
12.2.4 Spain
12.2.5 United Kingdom
12.2.6 Rest of Europe
12.3 Asia-Pacific
12.3.1 Australia
12.3.2 China
12.3.3 India
12.3.4 Japan
12.3.5 South Korea
12.3.6 Rest of Asia-Pacific
12.4 Middle East and Africa
12.4.1 South Africa
12.4.2 Saudi Arabia
12.4.3 U.A.E
12.4.4 Rest of Middle East and Africa
12.5 South and Central America
12.5.1 Brazil
12.5.2 Argentina
12.5.3 Rest of South and Central America
13. Industry Landscape
13.1 Mergers and Acquisitions
13.2 Agreements, Collaborations, Joint Ventures
13.3 New Product Launches
13.4 Expansions and Other Strategic Developments
14. Competitive Landscape
14.1 Heat Map Analysis by Key Players
14.2 Company Positioning and Concentration
15. Plasma Therapy Market – Key Company Profiles
15.1 BioLife Plasma Services
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
Note – Similar information would be provided for below list of companies

15.2 Takeda Pharmaceutical Company Limited
15.3 Biotest AG
15.4 CSL Ltd.
15.5 Grifols, S.A.
15.6 Kedrion S.p.A
15.7 ImmunoTek Bio Centers
15.8 Bio Products Laboratory Ltd.
15.9 China Biologic Products Holdings, Inc.
15.10 Octapharma AG
15.11 Origin, Inc.
16. Appendix
16.1 Glossary
16.2 About Research Team
16.3 Market Intelligence Cloud

LIST OF TABLES

NA

LIST OF FIGURES

NA

The List of Companies – Plasma Therapy Market
o Biotest
o CSL Ltd.
o Grifols
o Kedrion S.p.A
o China Biologics, Inc.
o Octapharma
o Cambrin Biologics
o LFB SA
o Biolife Plasma Services
o China Biologics Products

Reviews

There are no reviews yet.

Be the first to review “Plasma Therapy Market Size and Forecasts (2020-2030)”